title: Effects of intramuscular administration of 1α,25(OH)2D3 during skeletal muscle regeneration on regenerative capacity, muscular fibrosis, and angiogenesis.
abstract: The recent discovery of the vitamin D receptor (VDR) in regenerating muscle raises the question regarding the action of vitamin D3 on skeletal muscle regeneration. To investigate the action of vitamin D3 on this process, the tibialis anterior muscle of male C57BL/6 mice (10 wk of age) was injected with 1.2% BaCl2 to induce extensive muscle injury. The bioactive form of vitamin D3 [1α,25(OH)2D3] was administered daily via intramuscular injections during the regenerative phase (days 4-7 postinjury). Physiological and supraphysiological doses of 1α,25(OH)2D3 relative to 1 μg/kg muscle wet weight and mouse body weight were investigated. Muscle samples were collected on day 8 postinjury to examine proteins related to vitamin D3 metabolism (VDR, CYP24A1, and CYP27B1), satellite cell differentiation and regenerative muscle fiber formation [myogenin and embryonic myosin heavy chain (EbMHC)], protein synthesis signaling (Akt, p70 S6K1, 4E-BP1, and myostatin), fiber-type composition (fast and slow MHCs), fibrous formation (vimentin), and angiogenesis (CD31). Administration of 1α,25(OH)2D3 at physiological and supraphysiological doses enhanced VDR expression in regenerative muscle. Moreover, CYP24A1 and vimentin expression was increased, accompanying decreased myogenin and EbMHC expression at the supraphysiological dose. However, there was no change in CYP27B1, Akt, p70 S6K1, 4E-BP1, myostatin, fast and slow MHCs, or CD31 expression at any dose investigated. Taken together, administration of 1α,25(OH)2D3 at a supraphysiological dose decreased satellite cell differentiation, delayed regenerative muscle fiber formation, and increased muscular fibrosis. However, protein synthesis signaling, fiber-type composition, and angiogenesis were not affected by either 1α,25(OH)2D3 administration at a physiological or supraphysiological dose.
authors.affiliation: Department of Physiology, Faculty of Science, Mahidol University, Bangkok; and ratchakrit.sri@mahidol.ac.th.
authors.forename: Ratchakrit
authors.initials: R
authors.lastname: Srikuea
authors.affiliation: Department of Biopharmacy, Faculty of Pharmacy, Srinakharinwirot University, Nakhon Nayok, Thailand.
authors.forename: Muthita
authors.initials: M
authors.lastname: Hirunsai
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002762:Cholecalciferol / Q000008:administration & dosage*; D005355:Fibrosis / Q000188:drug therapy* / Q000378:metabolism; D007273:Injections, Intramuscular / Q000379:methods; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009024:Morphogenesis / Q000187:drug effects; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism; D009135:Muscular Diseases / Q000188:drug therapy* / Q000378:metabolism; D018008:Myogenin / Q000378:metabolism; D018995:Myosin Heavy Chains / Q000378:metabolism; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000378:metabolism; D018167:Receptors, Calcitriol / Q000378:metabolism; D012038:Regeneration / Q000187:drug effects*; D014945:Wound Healing / Q000187:drug effects
chemical_list: D018008:Myogenin; D018167:Receptors, Calcitriol; D002762:Cholecalciferol; D018995:Myosin Heavy Chains
keywords: angiogenesis; intramuscular injection; muscle regeneration; muscular fibrosis; vitamin D3